Media coverage
1
Media coverage
Title Icahn School of Medicine at Mount Sinai Researcher Updates Knowledge of Psoriasis (Once-daily roflumilast foam 0.3% for scalp and body psoriasis: A randomized, double-blind, vehicle-controlled phase 2b study) Media name/outlet Clinical Trials Daily Country/Territory United States Date 27/06/23 URL metabase.moreover.com/noarticleurl?type=psh&lni=68JT-80F1-DY7R-R2FH-00000-00 Persons Leon Kircik